Toxic liver disease with cholestasis
ICD-10 K71.0 is a billable code used to indicate a diagnosis of toxic liver disease with cholestasis.
Toxic liver disease with cholestasis refers to liver damage resulting from exposure to toxic substances, leading to impaired bile flow (cholestasis). Clinically, patients may present with symptoms such as jaundice, pruritus, dark urine, and pale stools, indicating bile accumulation in the liver. The liver, a vital organ in the digestive system, plays a crucial role in detoxification, metabolism, and bile production. Toxic agents can include drugs, alcohol, and industrial chemicals, which can cause hepatocyte injury and disrupt normal liver function. Disease progression may lead to acute liver failure if the toxic exposure is severe or prolonged. Diagnostic considerations include a thorough patient history, liver function tests, imaging studies, and possibly liver biopsy to assess the extent of damage. Identifying the specific toxin and the duration of exposure is essential for effective management and prognosis.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K71.0 covers liver damage due to toxic substances that result in cholestasis, including drug-induced liver injury, alcohol-related liver disease, and exposure to environmental toxins.
K71.0 should be used when cholestasis is present due to toxic liver disease, differentiating it from other liver conditions that do not involve cholestasis.
Documentation should include a detailed history of toxin exposure, clinical symptoms, laboratory test results indicating cholestasis, and any imaging studies performed.
